Used in pharmaceutical research as a key intermediate for synthesizing bioactive compounds, particularly in the development of antipsychotic and antidepressant drugs. Its structure supports binding to central nervous system receptors, making it valuable in medicinal chemistry for designing novel therapeutics. Also employed in the synthesis of kinase inhibitors and other targeted agents in oncology research. Shows potential in improving metabolic stability and blood-brain barrier penetration in drug candidates due to the trifluoromethyl and quinoline moieties.